BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Spectrum Chemical to Provide BASF Catalysts in Research Quantities to Pharmaceutical Customers in North America

  The agreement will enable customers making next-generation product breakthroughs to speed up commercialization and scale-up production.

  November 14, 2017

   · 

  3 min read
• Drug Development

  Achieve Life Science Announces Results of Clinical Study Demonstrating Similar Bioavailability of Cytisine in Fed and Fasted Subjects

  Study results demonstrated bioequivalence when cytisine was administered with or without food.

  November 14, 2017

   · 

  5 min read
• Pharm Country

  New Cadence Inline Diafiltration Modules Debuted at Pall Life Sciences Leadership Forum at Westborough, MA Center of Excellence

  The modules will be exclusively showcased this week during the next installation of Pall’s Leadership Forum series hosted in the Westborough, MA Center of Excellence.

  November 14, 2017

   · 

  2 min read
• Business

  Seres Therapeutics, MD Anderson Cancer Center, and the Parker Institute for Cancer Immunotherapy Announce a Collaboration to Support the Investigation of Microbiome Therapeutics for Immuno-Oncology

  The collaborators plan to initiate a randomized, placebo-controlled clinical study at MD Anderson, sponsored by the Parker Institute, in patients with advanced metastatic melanoma.

  November 14, 2017

   · 

  8 min read
• Biotech Beach

  Innovus Pharma Launches FlutiCare OTC Nasal Spray Allergy Relief in the U.S.

  FlutiCare will be available OTC with the same prescription strength and same delivery method as Flonase and ClariSpray.

  November 14, 2017

   · 

  5 min read
• Business

  ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update

  Net loss for the third quarter of 2017 was $17.0 million, or $0.59 per basic and diluted share.

  November 14, 2017

   · 

  8 min read
• Business

  VBL Therapeutics Announces Third Quarter 2017 Financial Results

  At September 30, 2017, we had cash, cash equivalents and short-term bank deposits totaling $28.2 million and working capital of $24.4 million.

  November 14, 2017

   · 

  9 min read
• Pharm Country

  Akers Biosciences’ UK Distributor Secures New Channel for Rapid Alcohol Breathalyzer

  The BreathScan Alcohol Detector is a proprietary, single-use, non-mechanical device that measures the user’s blood alcohol concentration in approximately 2 minutes, through a simple breath test.

  November 14, 2017

   · 

  4 min read
• Business

  EyeGate Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update

  EyeGate’s revenue for the third quarter of 2017 totaled $0.075 million, compared with $0.274 million in the third quarter of 2016.

  November 14, 2017

   · 

  6 min read
• Drug Development

  Poseida Therapeutics Presents on the Development of Allogeneic and Autologous BCMA-Specific CAR-T Therapies at Precision: Blood Cancer Summit

  The presentation expands on the anti-BCMA CAR-T development programs featuring Poseida’s proprietary piggyBac non-viral gene delivery system and Centyrin binding domain.

  November 14, 2017

   · 

  3 min read